Skip to main content

Funding round · 2026-11-10 · Healthcare

Efferon raises $4.6M

45
AI Score
Amount
$4.6M
Round
Undisclosed
Lead
Not disclosed
HQ
—

Efferon has raised €4.3 million from existing private investors in the DACH region to expand its hemoadsorption devices beyond critical care into healthy aging applications. The funding will support commercial expansion of Efferon LPS and Efferon NEO in Europe, India, and Latin America, plus its 21-distributor network and regulatory work. Efferon devices are used in 46 countries with over 30,000 treatments performed, and the company reported revenue above €1.1 million in 2025.

Participants:
—

Deal Dossier PRO

Pro feature
Deal Dossier for Efferon

Company, lead and participating investors, founders, and verified public contact channels — sourced, generated on demand.

Generate dossier — Pro
Already Pro? Sign in · See plans

Figures marked company-reported are unaudited. Not investment advice. Request a correction or removal (team@midu.si).

Recent Healthcare rounds

Browse all deals in the funding database →

Subscribe to the newsletters

Free, by email. No account needed. Pick one or both.

No spam. Unsubscribe anytime by emailing team@midu.si. Want alerts and full data? Sign up free (separate from the newsletter). Privacy.

Not investment advice. Midu summarizes public reports and SEC filings for information only. · Free API · Pricing